Logotype for OVS S.p.A.

OVS (OVS) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for OVS S.p.A.

Q4 2025 earnings summary

23 Dec, 2025

Executive summary

  • Net sales rose 6.2% to €1,631 million, with strong H2 growth and contributions from OVS, Upim, Stefanel, and new brands, despite adverse weather in H1.

  • Adjusted EBITDA increased by €13.0 million to €195.3 million, absorbing over €4 million in one-off losses and tax reversals.

  • Cash flow improved by 7% to €68.6 million, with three-year cumulative cash generation near €200 million despite significant investments.

  • Beauty segment exceeded €100 million in sales, up 20% year-over-year, and maintained double-digit growth.

  • Proposed dividend of €0.11 per share, up over 50% from the ordinary dividend and 57% from last year, with a €10 million buyback program continuation.

Financial highlights

  • Gross margin improved to 58.2%, up 91 basis points year-over-year, driven by normalized purchasing conditions.

  • Net income grew 2.6% to €77.9 million, penalized by higher tax rates due to regulatory changes.

  • EBIT increased 8.3% to €129.0 million; PBT up 8.0% to €109.5 million.

  • Q4 net sales rose 5.1% to €455.1 million; Q4 EBITDA impacted by one-off losses and tax reversals.

  • Net financial debt (adjusted) at €148.3 million, leverage ratio at 0.8x EBITDA.

Outlook and guidance

  • 2025 guidance anticipates continued EBITDA and cash flow growth, with stable or improving gross margin and reduced CapEx by at least €10-15 million.

  • Expansion in women’s and beauty segments, new launches, and dedicated store openings planned.

  • Network development and international partnerships expected to drive sales and EBITDA growth.

  • Cash flow in 2025 to benefit from reduced special investments; ongoing personnel cost increases anticipated.

  • Macroeconomic uncertainties and increased household costs may slow consumption.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more